A primary research-related activity of the Center for Diabetes and Metabolic Diseases (CDMD)’s Pilot and Feasibility (P&F) program is to foster the development of new diabetes-related investigators and provide seed-support for innovative, high-risk projects. The CDMD P&F program can fund up to three meritorious proposals at up to $45,000 each.
This funding opportunity announcement invites applications from investigators at Indiana University (IUSM, IUB, etc.), Indiana University-Purdue University Indianapolis (IUPUI), Purdue University, Ball State University, University of Notre Dame, University of Cincinnati, Emory University, and the Indiana Biomedical Research Institute (IBRI). The program will be particularly directed at new investigators and established investigators new to diabetes-related research. The program will also consider established diabetes investigators pursuing high impact/high risk projects or projects that are a significant departure from their usual work. The campuses are ideal for establishing interdisciplinary collaborations and forging new partnerships between basic scientists and clinical researchers, and such collaborations are encouraged.
Contact Information: Jeffrey S. Elmendorf, PhD email@example.com